• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TERUMO BCT SPECTRA OPTIA; SPECTRA OPTIA COLLECT SET Back to Search Results
Model Number 12120
Device Problems Excess Flow or Over-Infusion (1311); Use of Device Problem (1670); Improper or Incorrect Procedure or Method (2017)
Patient Problems Complaint, Ill-Defined (2331); No Known Impact Or Consequence To Patient (2692)
Event Date 08/01/2019
Event Type  malfunction  
Manufacturer Narrative
Investigation: a review of the device history record (dhr) for this unit showed no irregularities during manufacturing that were relevant to this issue.Investigation is in process.A follow-up report will be provided.
 
Event Description
The customer reported that while performing a procedure on spectra optia they had interface issues.Per the customer, during troubleshoot to verify the disposable set installation, it was discovered that saline roller clamp on the inlet line was left open creating an uncontrolled saline passage to the patient.Per the customer, the vital signs of the patient were assessed and found within the expected parameters.A diuretic was given to the patient.The patient information and outcome is not available at this time.The spectra optia collection set is not available for return because it was discarded by the customer.
 
Manufacturer Narrative
Based on the customer's statements, the root cause was the operator failed to follow the screen prompt to close the inlet saline roller clamp at the end of prime divert.
 
Manufacturer Narrative
This report is being filed to provide updated information in investigation: the procedural cautions section of the spectra optia apheresis systemessentials guide states that if the roller clamp on the saline line is left completely open when thepatient is connected, the patent will be quickly infused with a large volume of saline.Tbv*: 3651ml*calculated using nadler's total blood volume formula with the provided height (1.45m), weight(72kg), and gender (f).Ac to the patient: 986 mlsaline bolus: 1000 mlfinal fluid balance = 3651 + 1986 = (5637/3651) * 100 = 153%this final fluid balance represents the worst case scenario assuming no stem cell product wascollected into the collect bag, and all ac went back to the patient.On 08/26/2019, the operator was re-trained on the importance of following the screen promptsto close the inlet saline roller clamp.Investigation is in process, a follow-up report will be provided.
 
Event Description
Per the customer, after taking the diuretic, the patient's vital signs returned to normal.
 
Event Description
During follow-up with the customer, it was reported that a saline bolus of 1000ml was used forthis procedure.The customer declined to provide patient age.
 
Manufacturer Narrative
This report is being filed to provide additional information in investigation is in process.A follow-up report will be provided.
 
Manufacturer Narrative
This report is being filed to provide additional information in h.6 and h.10.Updated investigation: tbv*: 3651ml *calculated using nadler's total blood volume formula with the provided height (1.45m), weight (72kg), and gender (f).Ac to the patient: 986 ml saline bolus: 1000 ml intended final fluid balance, without saline bolus = [(3651+986)/3651]*100 = 127% final fluid balance with saline bolus = [(3651+1986)/3651]*100 = 154% the final fluid balance with the saline bolus represents the worst case scenario, assuming no stem cell product was collected into the collect bag, and all ac went back to the patient.This fluid balance is an additional 27% higher than the final fluid balance reported by the device and is more than 20% higher than the intended fluid balance for the collection procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SPECTRA OPTIA
Type of Device
SPECTRA OPTIA COLLECT SET
Manufacturer (Section D)
TERUMO BCT
lakewood CO 80215
MDR Report Key8926156
MDR Text Key155700924
Report Number1722028-2019-00240
Device Sequence Number1
Product Code GKT
UDI-Device Identifier05020583121201
UDI-Public05020583121201
Combination Product (y/n)N
PMA/PMN Number
BK150251
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Type of Report Initial,Followup,Followup,Followup,Followup
Report Date 08/23/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/01/2020
Device Model Number12120
Device Catalogue Number12120
Device Lot Number1809213330
Was Device Available for Evaluation? No
Was the Report Sent to FDA? Yes
Initial Date Manufacturer Received 08/01/2019
Initial Date FDA Received08/23/2019
Supplement Dates Manufacturer Received08/27/2019
09/25/2019
11/20/2019
01/08/2020
Supplement Dates FDA Received09/17/2019
10/11/2019
11/25/2019
01/31/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other; Required Intervention;
Patient Weight72
-
-